Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02438813 · ClinicalTrials.gov registry record
Condition of Submental Fullness and Treatment Outcomes Registry
A clinical trial, sponsored by Kythera Biopharmaceuticals.
- Completed
- Registry status
- 1,029
- Enrollment target
NCT02438813 is a clinical trial that has completed, run by Kythera Biopharmaceuticals. The registered enrollment target is 1,029 participants.
The verdict
NCT02438813 has completed, sponsored by Kythera Biopharmaceuticals.
- COMPLETED
- Registry status
- 1,029 participants
- Enrollment target
Study Summary
The primary objective of this registry is to develop a comprehensive understanding of the condition of submental (SM) fullness due to submental fat (SMF), how it is treated in current clinical practice, and the risks and benefits associated with its treatment.
Interventions
- DRUG Deoxycholic acid
- PROCEDURE Surgical Procedures
- PROCEDURE Laser Liposuction
- DEVICE Energy Devices
- OTHER Other Treatments
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,029 participants |
| Start Date | 2015-05-11 |
| Est. Completion | 2016-11-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02438813
The ClinicalTrials.gov registry entry for NCT02438813 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,029 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kythera Biopharmaceuticals, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Deoxycholic acid is the first listed.
NCT02438813 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02438813 about?
NCT02438813 is a clinical study titled "Condition of Submental Fullness and Treatment Outcomes Registry". The primary objective of this registry is to develop a comprehensive understanding of the condition of submental (SM) fullness due to submental fat (SMF), how it is treated in current clinical practice, and the risks and benefits associated with its treatment.
What is the current status of trial NCT02438813?
This trial is currently completed. The enrollment target is 1,029 participants. The study started on 2015-05-11. Estimated completion is 2016-11-10.
What interventions are being tested in trial NCT02438813?
The interventions under investigation include: Deoxycholic acid (DRUG), Surgical Procedures (PROCEDURE), Laser Liposuction (PROCEDURE), Energy Devices (DEVICE), Other Treatments (OTHER).
Who is sponsoring clinical trial NCT02438813?
This trial is sponsored by Kythera Biopharmaceuticals, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.